cGMP-specific 3',5'-cyclic phosphodiesterase; cGMP-binding cGMP-specific phosphodiesterase; CGB-PDE (PDE5A)
Jump to navigation
Jump to search
Function
- plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides
- catalyzes the specific hydrolysis of cGMP to 5'-GMP
- purine metabolism; 3',5'-cyclic GMP degradation; GMP from 3',5'-cyclic GMP: step 1/1
- phosphorylation is regulated by binding of cGMP to the two allosteric sites (putative)
guanosine 3',5'-cyclic phosphate + H2O = guanosine 5'-phosphate
- binds 2 divalent metal cations per subunit
- site 1 may preferentially bind Zn+2
- site 2 has a preference for Mg+2 &/or Mn+2
Structure
- composed of a C-terminal catalytic domain containing two putative divalent metal sites & an N-terminal regulatory domain
- contains two homologous allosteric cGMP-binding regions, A & B
- belongs to the cyclic nucleotide phosphodiesterase family
- contains 2 GAF domains
Alternative splicing
named isoforms=2
Expression
- expressed in aortic smooth muscle cells, heart, placenta, skeletal muscle & pancreas
- lesser expression in brain, liver & lung
Pharmacology
- sildenafil (Viagra) used in treatment of erectile dysfunction is a highly selective & potent inhibitor of PDE5A
- also inhibited by zaprinast